Mycalin A (1, Figure 1) is an antiproliferative metabolite isolated from the marine sponge Mycale rotalis that induces cell death by an apoptotic mechanism. Recent studies conducted in our group have shown that a degraded lactone analogue (2, Figure 1) of mycalin A retains the cytotoxic activity of the original substance while displaying a limited killing effect on human dermal fibroblasts (HDF) healthy cells used as control. Preparation of several synthetic analogues of mycalin A, including 2, has shown that their anti-tumour activity is mostly associated with the presence in the molecule of the THF or a THF-mimicking left-hand portion. Based on these observations, we have synthesised some simplified lactone analogues of 2 (Figure 2), including C-3 epimeric analogues, starting from D-ribonolactone and D-xylonolactone. Preliminary results on their cytotoxic activity have shown that some of them possess good antiproliferative activity on the same human tumour cell lines used for assays on mycalin A and on its lactone derivative 2. The identification of the biological target through the Drug Affinity Responsive Target Stability (DARTS) technique is currently under investigation and will also be discussed.
Synthesis and Antiproliferative Activity of Simplified Lactone Analogues of Mycalin A, a Polybrominated Metabolite of Marine Origin / Piccialli, Vincenzo; Marino, P.; Borbone, Nicola; Terracciano, Monica; Capasso, Domenica; DI GAETANO, Sonia. - (2022), pp. 237-237. (Intervento presentato al convegno XL CDCO tenutosi a Teatro Al Massimo, Palermo nel 11-15 settembre 2022).
Synthesis and Antiproliferative Activity of Simplified Lactone Analogues of Mycalin A, a Polybrominated Metabolite of Marine Origin
vincenzo piccialli
;nicola borbone;monica terracciano;domenica capasso;sonia di gaetano
2022
Abstract
Mycalin A (1, Figure 1) is an antiproliferative metabolite isolated from the marine sponge Mycale rotalis that induces cell death by an apoptotic mechanism. Recent studies conducted in our group have shown that a degraded lactone analogue (2, Figure 1) of mycalin A retains the cytotoxic activity of the original substance while displaying a limited killing effect on human dermal fibroblasts (HDF) healthy cells used as control. Preparation of several synthetic analogues of mycalin A, including 2, has shown that their anti-tumour activity is mostly associated with the presence in the molecule of the THF or a THF-mimicking left-hand portion. Based on these observations, we have synthesised some simplified lactone analogues of 2 (Figure 2), including C-3 epimeric analogues, starting from D-ribonolactone and D-xylonolactone. Preliminary results on their cytotoxic activity have shown that some of them possess good antiproliferative activity on the same human tumour cell lines used for assays on mycalin A and on its lactone derivative 2. The identification of the biological target through the Drug Affinity Responsive Target Stability (DARTS) technique is currently under investigation and will also be discussed.File | Dimensione | Formato | |
---|---|---|---|
ATTI XL CDCO 237.pdf
accesso aperto
Descrizione: abstract
Tipologia:
Altro materiale allegato
Licenza:
Dominio pubblico
Dimensione
213.69 kB
Formato
Adobe PDF
|
213.69 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.